Atria Investments’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.57M Buy
21,845
+1,460
+7% +$224K 0.04% 479
2025
Q4
$3.55M Sell
20,385
-1,028
-5% -$188K 0.04% 495
2025
Q3
$3.08M Buy
21,413
+4,603
+27% +$564K 0.04% 563
2025
Q2
$1.69M Buy
16,810
+7,219
+75% +$552K 0.02% 795
2025
Q1
$732K Buy
9,591
+4,359
+83% +$333K 0.01% 1140
2024
Q4
$361K Buy
5,232
+247
+5% +$17.8K ﹤0.01% 1493
2024
Q3
$364K Buy
4,985
+1,902
+62% +$140K ﹤0.01% 1505
2024
Q2
$207K Buy
+3,083
New +$120K ﹤0.01% 1807

Other funds holding INSM

Atria Investments's INSM Position: Q1 2026 in Review

Atria Investments increased its Insmed (INSM) stake by 7.2% in Q1 2026, buying an estimated $224K and bringing the position to 21,845 shares worth $3.57M. The position accounts for 0.04% of the portfolio, ranked #479.

Atria Investments first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Atria Investments held 21,845 shares of Insmed worth $3.57M as of Q1 2026.
  • Atria Investments bought 1,460 Insmed shares in Q1 2026, an estimated $224K.
  • Insmed made up 0.04% of Atria Investments's portfolio in Q1 2026, its #479 holding.
  • Atria Investments first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.